MENU
DEC 03, 2020 10:30 AM PST

Accelerating vaccine development using a next generation microfluidic CE platform

Presented at: Coronavirus Series
Sponsored by: PerkinElmer
Speaker

Abstract

When producing a quality vaccine, all manufacturers must confirm the purity as well as the stability of their formulation and final product. Sample quantity and measurement time are often the throughput bottlenecks encountered during the process. As PerkinElmer’s LabChip GXII Touch addresses these specific gaps, we’ve developed a literature-centric webinar.

Learning Objectives:

1. The vaccine development and manufacturing process

2. The key applications of microfluidic CE in vaccine process development


Connect with us